The content is available as a PDF (250.5 KB).
Bibliografía
- 1.Flórez J., Armijo J.A., Mediavilla A. Masson; Barcelona: 1992. (Farmacología). [Google Scholar]
- 2.Barclay T.S., Tsourounis C., McCart G.M. Glucosamine. Ann Pharmacother. 1998;32:574–579. doi: 10.1345/aph.17235. [DOI] [PubMed] [Google Scholar]
- 3.Towheed T.E. Glucosamine and chondroitin for treating symptoms of osteoarthritis. Evidence is widely touted but incomplete. Jama. 2000;283:1483–1484. doi: 10.1001/jama.283.11.1483. [DOI] [PubMed] [Google Scholar]
- 4.McAlindon T.E., La Balley M.P., Gulin J.P., Felson D.T. Glucosamine and chondroitin for treatment of osteoarthritis. A systematic quality assessment and metaanalysis. Jama. 2000;283:1469–1475. doi: 10.1001/jama.283.11.1469. [DOI] [PubMed] [Google Scholar]
- 5.Communiqué: glucosamine sulfate: hyperglycemia. Can Adverse Drug React Newsl. 2000;10:4. [Google Scholar]
- 6.Ficha técnica de Xicil®. Laboratorios Rottapharm, S.A. Valencia
- 7.Ficha técnica de Hespercorbin®. LaboratoriosFides-Ecopharma, S.A., 1996
- 8.Base de datos Micromedex Drugdex,2001. Micromedex Health care Series. 2001;109 expres 9/2001. [Google Scholar]
- 9.Towheed T.E., Anastassiades T.P., Shea B., Houpt J., Welch V., Hochberg M.C. The Cochrane Library,Issue 2. Update Software; Oxford: 2002. Glucosamine therapy for treating osteoarthritis (Cochrane Review) [DOI] [PubMed] [Google Scholar]
- 10.Communiqué: Warfarin and glucosamine: interaction. Can Adverse Drug React Newsl. 2001;11:8. [Google Scholar]